Integrated Molecular Analysis of Tamoxifen-Resistant Invasive Lobular Breast Cancer Cells Identifies MAPK and GRM/mGluR Signaling as Therapeutic Vulnerabilities

Invasive lobular breast cancer (ILC) is an understudied malignancy with distinct clinical, pathological, and molecular features that distinguish it from the more common invasive ductal carcinoma (IDC). Mounting evidence suggests that estrogen receptor-alpha positive (ER+) ILC has a poor response to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cell Endocrinol
Main Authors: Stires, Hillary, Heckler, Mary M., Fu, Xiaoyong, Zhao, Li, Grasso, Catherine S., Quist, Michael J., Lewis, Joseph A., Klimach, Uwe, Zwart, Alan, Mahajan, Akanksha, Győrffy, Balázs, Cavalli, Luciane R., Riggins, Rebecca B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5858970/
https://ncbi.nlm.nih.gov/pubmed/28935545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mce.2017.09.024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados